France will ensure free COVID-19 vaccinations for all who are in its social security system and has earmarked 1.5 billion euros of next year’s social security budget to cover the cost, Prime Minister Jean Castex said on Thursday. Castex said the vaccination campaign would begin in a matter of weeks, pending regulatory approval by the European Medicines Agency. The inoculation programme would be staggered over three categories of people, he said, commencing with the most vulnerable in nursing homes. “The vaccination will be free for all,” Castex told a press conference. France has ordered some 200 million doses from different pharmaceutical companies developing vaccines, Castex said, enough to inoculate 100 million people – more than France’s population. The COVID-19 vaccination will be vol...
A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe. Early analysis of trials involving 20,000 volunteers in Britain and Brazil show the vaccine is at least 62% effective after two doses. In volunteers given a different dosing regimen — a half dose, followed by a full dose — that figure rose to 90%. The average efficacy of the two dosing methods is 70%. None of those given the vaccine developed severe COVID-19 illness. Andrew Pollard, director of the Oxford Vaccine Group, said the recent successful trials of three different vaccines by Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, represent a...